Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia

Published:2021-07-16 Issue:6 Volume:43 Page:1483-1490
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hematol

Author:

Lu Jingtao¹^ORCID,Chen Meiyu¹,Hua Haiying²,Qin Wei¹,Zhang Ri³,Lu Xuzhang¹,Chao Hongying¹^ORCID

Affiliation:

1. Department of Hematology Affiliated Changzhou Second Hospital of Nanjing Medical University Changzhou China

2. Department of Hematology The Affiliated Hospital of Jiangnan University Wuxi China

3. Department of Hematology The First Affiliated Hospital of Suzhou University Jiangsu Institute of Hematology Key Laboratory of Thrombosis and Hemostasis of Ministry of Health Suzhou China

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13648

Reference34 articles.

1. IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication

2. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

3. Genomic Classification and Prognosis in Acute Myeloid Leukemia

4. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia

5. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients;International Journal of Laboratory Hematology;2023-07-30

2. Biosynthesis and Significance of Fatty Acids, Glycerophospholipids, and Triacylglycerol in the Processes of Glioblastoma Tumorigenesis;Cancers;2023-04-06

3. Effects of cancer-associated point mutations on the structure, function, and stability of isocitrate dehydrogenase 2;Scientific Reports;2022-11-05

4. Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches;OncoTargets and Therapy;2022-11

5. Recent advances of IDH1 mutant inhibitor in cancer therapy;Frontiers in Pharmacology;2022-08-24